Nektar Therapeutics:Received Letter From Nasdaq Notifying Co It Regained Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq
Nektar Therapeutics:收到納斯達克的來信,通知該公司已恢復遵守繼續在納斯達克上市的最低投標價要求
Nektar Therapeutics:Received Letter From Nasdaq Notifying Co It Regained Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq
Nektar Therapeutics:收到納斯達克的來信,通知該公司已恢復遵守繼續在納斯達克上市的最低投標價要求
使用瀏覽器的分享功能,分享給你的好友吧